We are live on ! Find out more
INSY

Insys Therapeutics, Inc.
INSY

Delisted

INSY was delisted on the 18th of June, 2019.

Back to rankings

103 hedge funds and large institutions have $94.2M invested in Insys Therapeutics, Inc. in 2018 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 21 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 21

12% more capital invested

Capital invested by funds: $84M → $94.2M (+$10.1M)

6% less funds holding

Funds holding: 110 → 103 (-7)

30% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 20

43% less call options, than puts

Call options by funds: $3.55M | Put options by funds: $6.18M

Holders
103
Holders Change
-7
Holders Change %
-6.36%
% of All Funds
2.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
31
Reduced
21
Closed
20
Calls
$3.55M
Puts
$6.18M
Net Calls
-$2.63M
Net Calls Change
-$2.11M

Top Buyers

Rank Fund Capital Flow
1
EMG
ETF Managers Group
New Jersey
+$1.53M
2
BlackRock
BlackRock
New York
+$1.35M
3
Millennium Management
Millennium Management
New York
+$1.19M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.06M
5
JG
Jefferies Group
New York
+$357K

Top Sellers

Rank Fund Capital Flow
1
Norges Bank
Norges Bank
Norway
-$3.43M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.47M
3
PAM
Panagora Asset Management
Massachusetts
-$1M
4
Citadel Advisors
Citadel Advisors
Florida
-$453K
5
FIM
Freedom Investment Management
Connecticut
-$399K
Name Holding Trade Value Shares
Change 		Change in
Stake
FRM
101
Fox Run Management
Connecticut
– -$82K -13,616 Closed
Squarepoint
102
Squarepoint
New York
– -$64K -10,521 Closed
LPL Financial
103
LPL Financial
California
– -$62K -10,212 Closed
FANJ
104
Financial Architects (New Jersey)
New Jersey
– -$10.5K -1,500 -100%
KF
105
Krilogy Financial
Missouri
– -$8K -1,403 Closed
RFA
106
Reilly Financial Advisors
California
– -$6K -1,000 Closed
SWP
107
Stratos Wealth Partners
Ohio
– -$5K -863 Closed
AWA
108
Acorn Wealth Advisors
Michigan
– -$5K -730 Closed
SIM
109
Sonora Investment Management
Arizona
– -$3.62K -600 Closed
IWM
110
IHT Wealth Management
Illinois
– -$2K -365 Closed
WT
111
Whittier Trust
California
– -$1K -111 Closed
FGAM
112
Financial Gravity Asset Management
Texas
– -$14 -2 -4%
CF
113
Centaurus Financial
California
– +$35 +5 New
OFW
114
Omnia Family Wealth
Florida
– +$209 +30 New
FHA
115
Flagship Harbor Advisors
Massachusetts
– +$732 +105 New
1 2 3 4
5

INSY Hedge Fund Activity: Q2 2018 in Review

103 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Insys Therapeutics, Inc. (INSY) for Q2 2018, worth a combined $94.2M — up 12% from $84M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of INSY and 14 opened new positions — a net loss of 6 holders — while 21 trimmed existing stakes and 31 added.

The largest buyer was ETF Managers Group, adding an estimated $1.53M. The largest seller was Norges Bank, cutting an estimated $3.43M.

  • 103 institutional investors held Insys Therapeutics, Inc. (INSY) as of Q2 2018, down from 110 in Q1 2018.
  • Funds reported $94.2M of Insys Therapeutics, Inc. stock for Q2 2018, up 12% quarter-over-quarter.
  • 14 funds opened new Insys Therapeutics, Inc. positions in Q2 2018 and 20 closed out, a net change of -6 holders.
  • The largest Insys Therapeutics, Inc. buyer in Q2 2018 was ETF Managers Group, an estimated $1.53M added.
  • The largest Insys Therapeutics, Inc. seller in Q2 2018 was Norges Bank, an estimated $3.43M sold.

Based on aggregated 13F filings for Q2 2018.